(Q51579060)

7 April 2018

title

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. (English)

1 reference

7 April 2018

1 reference

N Tomioka

1

1 reference

7 April 2018

S Oba

2

1 reference

7 April 2018

M Ohira

3

1 reference

7 April 2018

A Misra

4

1 reference

7 April 2018

J Fridlyand

5

1 reference

7 April 2018

S Ishii

6

1 reference

7 April 2018

Y Nakamura

7

1 reference

7 April 2018

E Isogai

8

1 reference

7 April 2018

T Hirata

9

1 reference

7 April 2018

Y Yoshida

10

1 reference

7 April 2018

S Todo

11

1 reference

7 April 2018

Y Kaneko

12

1 reference

7 April 2018

D G Albertson

13

1 reference

7 April 2018

D Pinkel

14

1 reference

7 April 2018

B G Feuerstein

15

1 reference

7 April 2018

A Nakagawara

16

1 reference

7 April 2018

language of work or name

English

0 references

publication date

16 July 2007

1 reference

7 April 2018

published in

Oncogene

1 reference

7 April 2018

volume

27

1 reference

7 April 2018

page(s)

441-449

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210661

exact match

0 references

cites work

Chromosome aberrations in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Chromosome 1p and 11q deletions and outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

CHD5 is a tumor suppressor at human 1p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Biological aspects of neuroblastomas identified by mass screening in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Fully automatic quantification of microarray image data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

The NGF story and neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Neuroblastoma: biology and molecular and chromosomal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Assembly of microarrays for genome-wide measurement of DNA copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Screening of infants and mortality due to neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Neuroblastoma, well-designed evaluations, and the optimality of research funding: ask not what your country can do for you ...

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Deletion of chromosome 11 and of 14q sequences in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neurob

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Neuroblastoma: the result of multistep transformation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210661

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210661

1 reference

7 April 2018

PubMed ID

17637744

1 reference

7 April 2018